Literature DB >> 21945386

Accuracy of the actibelt(®) accelerometer for measuring walking speed in a controlled environment among persons with multiple sclerosis.

Robert W Motl1, Madeline Weikert, Yoojin Suh, Jacob J Sosnoff, John Pula, Cristina Soaz, Michaela Schimpl, Christian Lederer, Martin Daumer.   

Abstract

BACKGROUND: Advances in portable sensor technology have opened an era for objective, real-life monitoring of walking speed in persons with multiple sclerosis (MS).
PURPOSE: The present study examined the accuracy of the actibelt(®) accelerometer for measuring walking speed during a standard 6-min walk (6MW) and the possibility that disability status influenced the degree of accuracy among persons with MS.
METHODS: On a single testing session, 51 persons with MS and Expanded Disability Status Scale scores between 2.0 and 6.5 performed a 6MW while wearing an actibelt(®) in the body's sagittal symmetry plane and close to the body's centre of mass.
RESULTS: All 51 participants completed the 6MW without stopping, falling, or any adverse events, and the actibelt(®) provided walking speed data for each of the participants. The actibelt(®) significantly overestimated walking speed (actual minus actibelt(®)) by a mean±standard deviation of -0.12±0.17 m/s for the overall sample (p<0.0001). There was no significant overestimation in the sample with mild disability (-0.02±0.11 m/s), but there was in the samples with moderate (-0.10±0.16 m/s) and severe (-0.26±0.12 m/s) disability.
CONCLUSION: The actibelt(®) is ready for real-life monitoring of walking speed in persons with mild MS, but caution is necessary when interpreting the accuracy of the walking speed data for those with MS who have moderate and severe disability.
Copyright © 2011 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21945386     DOI: 10.1016/j.gaitpost.2011.09.005

Source DB:  PubMed          Journal:  Gait Posture        ISSN: 0966-6362            Impact factor:   2.840


  22 in total

1.  Feeling older, walking slower-but only if someone's watching. Subjective age is associated with walking speed in the laboratory, but not in real life.

Authors:  Nanna Notthoff; Johanna Drewelies; Paulina Kazanecka; Elisabeth Steinhagen-Thiessen; Kristina Norman; Sandra Düzel; Martin Daumer; Ulman Lindenberger; Ilja Demuth; Denis Gerstorf
Journal:  Eur J Ageing       Date:  2018-02-01

Review 2.  Motion sensors in multiple sclerosis: Narrative review and update of applications.

Authors:  Jeffer Eidi Sasaki; Brian Sandroff; Marcas Bamman; Robert W Motl
Journal:  Expert Rev Med Devices       Date:  2017-10-18       Impact factor: 3.166

Review 3.  Next Steps in Wearable Technology and Community Ambulation in Multiple Sclerosis.

Authors:  Mikaela L Frechette; Brett M Meyer; Lindsey J Tulipani; Reed D Gurchiek; Ryan S McGinnis; Jacob J Sosnoff
Journal:  Curr Neurol Neurosci Rep       Date:  2019-09-04       Impact factor: 5.081

4.  Measurement of the number of lumbar spinal movements in the sagittal plane in a 24-hour period.

Authors:  Antonius Rohlmann; Tobias Consmüller; Marcel Dreischarf; Maxim Bashkuev; Alexander Disch; Esther Pries; Georg N Duda; Hendrik Schmidt
Journal:  Eur Spine J       Date:  2014-09-20       Impact factor: 3.134

5.  Continuous Monitoring of Patient Mobility for 18 Months Using Inertial Sensors following Traumatic Knee Injury: A Case Study.

Authors:  Arne Mueller; Holger Hoefling; Timur Nuritdinow; Nicholas Holway; Matthias Schieker; Martin Daumer; Ieuan Clay
Journal:  Digit Biomark       Date:  2018-08-02

Review 6.  Wearable motion sensors to continuously measure real-world physical activities.

Authors:  Bruce H Dobkin
Journal:  Curr Opin Neurol       Date:  2013-12       Impact factor: 5.710

7.  Evidence for the different physiological significance of the 6- and 2-minute walk tests in multiple sclerosis.

Authors:  Robert W Motl; Yoojin Suh; Swathi Balantrapu; Brian M Sandroff; Jacob J Sosnoff; John Pula; Myla D Goldman; Bo Fernhall
Journal:  BMC Neurol       Date:  2012-03-01       Impact factor: 2.474

Review 8.  The clinical relevance of outcomes used in late-onset Pompe disease: can we do better?

Authors:  Robin Lachmann; Benedikt Schoser
Journal:  Orphanet J Rare Dis       Date:  2013-10-12       Impact factor: 4.123

9.  Ecological validity of walking capacity tests in multiple sclerosis.

Authors:  J P Stellmann; A Neuhaus; N Götze; S Briken; C Lederer; M Schimpl; C Heesen; M Daumer
Journal:  PLoS One       Date:  2015-04-16       Impact factor: 3.240

Review 10.  Physical Activity Monitoring in Patients with Neurological Disorders: A Review of Novel Body-Worn Devices.

Authors:  Oonagh M Giggins; Ieuan Clay; Lorcan Walsh
Journal:  Digit Biomark       Date:  2017-06-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.